|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 408.90 DKK | +1.09% |
|
-1.97% | -42.85% |
| May. 20 | Danish Biotech Zealand Pharma Names Chief Development Officer | MT |
| May. 19 | Deutsche Bank lowers its target price for Zealand Pharma to 485 Danish kroner (750), reiterates hold | FW |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 485.7 | 558 | 585.5 |
| Spread/Res. | -15.81% | -26.72% | -30.16% |
| Spread/Supp. | +3.13% | +3.13% | +34.07% |
| Support | 396.5 | 396.5 | 305 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ZEAL Stock
- Charts Zealand Pharma A/S
Select your edition
All financial news and data tailored to specific country editions
